ARA-290 Pre-Mixed Pen Australia
ARA-290 is a synthetic peptide derived from a small segment of erythropoietin (EPO), specifically tailored to provide tissue-protective and anti-inflammatory effects without the erythropoietic (red blood cell production) activity associated with full-length EPO. This design allows ARA-290 to focus on activating specific targets, such as the innate repair receptor (IRR), a combination of the EPOR and CD131 receptor subunits, which are upregulated during tissue stress or injury.
Australia Clinical studies have found that this peptide works by modulating inflammatory responses and promoting tissue repair. By binding to the IRR, ARA-290 reduces pro-inflammatory cytokines and recruits local healing mechanisms to damaged tissues. These actions help to mitigate pain, protect against nerve damage, and enhance recovery in a range of conditions. Unlike traditional inflammatory treatments, ARA-290 does not increase blood viscosity or erythropoiesis, making it safer for long-term use.
ARA-290 shows potential in animal studies for managing chronic neuropathic pain, especially in conditions like small fiber neuropathy, where nerve damage leads to severe sensory impairment. Additionally, it holds promise in treating inflammatory diseases, such as sarcoidosis, systemic lupus erythematosus, rheumatoid arthritis and diabetes-related complications like diabetic neuropathy. Australia Researchers are exploring its applications in wider contexts, including cardiovascular health, as its targeted action and safety profile position it as a valuable therapeutic candidate for inflammatory and tissue-related disorders. Read more about the mechanism of action, further laboratory studies and potential benefits of ARA-290 peptide.
Benefits of ARA-290 Pre-Mixed Pen Australia
The ARA-290 pre-mixed peptide pens are designed with a dosage adjustment dial and come with a pre-filled cartridge of your chosen peptide for research use. The package also includes single-use needle tips in a compact carry case. Research professionals value these pens for their efficiency, accuracy, and ease of use compared to traditional syringes and vials in laboratory studies.
Key benefits of the ARA-290 Pre-Mixed Peptide Pen:
- Effortless Operation – Ideal for those unfamiliar with peptide preparation.
- Convenient Portability – Lightweight and easy to transport.
- Accurate Dosing – Fine-tune doses with the built-in dial ensuring accurate dosages for laboratory purposes.
- Low Contamination Risk – Eliminates the need for manual mixing as the solution is pre-mixed with bacteriostatic water.
PharmaGrade.Store offers additional accessories, including replacement needles, for all your research needs. Browse their selection online.
Shop ARA-290 Pre-Mixed Pen for clinical research purposes Australia from PharmaGrade.Store.
ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY
DISCLAIMER: All products sold by PharmaGrade.Store are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.
Pen Instructions
All of our injection pens will release 0.5ml water every 60 dials.
We mix this product with 2ml water therefore to calculate what 1 dial on the pen will release you will need to divide the full amount of product (e.g. if the product has 5mg divide 5000mcgs) by the full amount of dials on the pen (240)
